Rivaroxaban Hypericum Trial

Clinical trial NCT03796377 · COMPLETED

Trial details

NCT number: NCT03796377
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Interaction Study

Start date: 2019-02-13
Primary completion: 2019-04-09
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.